National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

interferon alfacon-1
An analogue of consensus interferon which contains an additional methionyl amino acid residue. Consensus interferon (also known as interferon alfacon-1, rCon-IFN, and CIFN) is a genetically engineered synthetic interferon created from the most common amino acid sequences from the naturally occurring alpha interferons. Alpha interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune-modulating effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:consensus interferon
IFN Alfacon-1
Interferon Consensus, Methionyl
interferon consensus, methionyl
methionyl interferon consensus
methionyl-interferon-consensus
Recombinant Consensus Interferon
Recombinant methionyl human consensus interferon
US brand name:Infergen
Foreign brand name:Advaferon
Abbreviations:CIFN
r-metHuIFN-Con1



Previous:Innohep, INO-1001, inosine dialdehyde, inositol, inotuzumab ozogamicin
Next:interleukin-12 gene, interleukin-2 gene, interleukin-2 liposome, IntraDose, intranasal ketamine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov